Ambev S.A. (LON:0A6X)
2.509
+0.008 (0.32%)
At close: Dec 19, 2025
Ambev Market Cap
Ambev has a market cap or net worth of 28.13 billion as of December 19, 2025. Its market cap has decreased by -1.57% in one year.
Market Cap
28.13B
Enterprise Value
25.92B
Revenue
12.63B
Ranking
n/a
PE Ratio
12.56
Stock Price
2.51
Market Cap Chart
Since November 11, 2013, Ambev's market cap has decreased from 45.31B to 28.13B, a decrease of -37.93%. That is a compound annual growth rate of -3.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 28.13B | 18.82% |
| Dec 30, 2024 | 23.67B | -32.47% |
| Dec 28, 2023 | 35.05B | -3.03% |
| Dec 29, 2022 | 36.15B | 12.12% |
| Dec 30, 2021 | 32.24B | -7.97% |
| Dec 30, 2020 | 35.04B | -37.06% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 212.02B |
| HSBC Holdings | 200.10B |
| Shell | 154.88B |
| Unilever | 108.28B |
| Rio Tinto Group | 99.46B |
| Rolls-Royce Holdings | 97.94B |
| British American Tobacco p.l.c. | 92.05B |
| GSK plc | 73.11B |